Economic News Pfizer plays hardball in weight-loss drug fightNovember 4, 20250 Palantir has raised its revenue guidance for 2025 after a strong quarterly performance. In other news, Pfizer has taken legal…
Stock Market US FDA flags dosing risks from compounded versions of Novo’s weight-loss drug By ReutersAugust 6, 20240 The U.S. Food and Drug Administration issued a warning on Friday regarding dosing errors associated with compounded versions of Novo…
